compound introduction
物理描述 | 多西拉敏是无色透明液体。(NTP, 1992)
CAS number:469-21-6 molecular formula:C17H22N2O
物理描述 | 多西拉敏是无色透明液体。(NTP, 1992)
| Chinese alias | 多西拉敏 | ||
| English alias | ()-Doxylamine | 2-(.alpha.-(2-(Dimethylamino)ethoxy)-.alpha.-methylbenzyl)pyridine | 2-(.ALPHA.(2-(DIMETHYLAMINO)ETHOXY)-.ALPHA.-METHYLBENZYL)PYRIDINE | BCP09058 | 5-21-03-00508 (Beilstein Handbook Reference) | CHEBI:51380 | N,N-dimethyl-2-(1-phenyl-1-(py | ||
| CAS number | 469-21-6 | molecular formula | C17H22N2O |
| molecular weight | 270.37 | Exact mass | - |
| PSA | 25.4 | logp | 2.5 |
| CAS | 469-21-6 |
| UNII | 95QB77JKPL |
| RXCUI | 3642 |
| HMDB ID | HMDB0001936 |
| KEGG ID | D07878 |
| ChEBI ID | 51380 |
| Wikidata | Q423390 |
| ChEMBL ID | CHEMBL1004 |
| Wikipedia | Doxylamine |
| DrugBank ID | DB00366 |
| DrugCentral | 962 |
| PharmGKB ID | PA449419 |
| PubChem CID | 3162 |
| Nikkaji Number | J5.925K |
| NCI 词表代码 | C61738 |
| Pharos Ligand ID | DXTRAP97HAY5 |
| DSSTox Substance ID | DTXSID1022970 |
| Metabolomics Workbench ID | 37942 |
| European Community (EC) Number | 207-414-2 |
| PubChem Reference Collection SID | 483925356 |
| International Nonproprietary Names (INN) | DOXYLAMINE |
| LogP | 2.151 |
| XLogP3 | XLogP3-AA: 2.5 |
| 沸点 | 137-141 °C @ 0.5 MM HG |
| 熔点 | 晶体;熔点:100-104 °C;1%水溶液pH值在4.9与5.1之间/琥珀酸盐/ |
| 复杂性 | 276 |
| 折射率 | 折射率:计算值1.525(ALPHA),1.563(BETA),1.598(GAMMA) |
| 溶解度 | 溶于酸。 |
| 蒸气压 | 轻微挥发性 |
| Exact Mass | 270.173213330 |
| Human Drugs | 药物 |
| 形式电荷 | 0 |
| 物理描述 | 固体 |
| 颜色/形态 | LIQ |
| 重原子计数 | 20 |
| Molecular Weight | 270.37 |
| Monoisotopic Mass | 270.173213330 |
| 其他实验性质 | 暴露于光线下会变暗。 |
| 可旋转键计数 | 6 |
| 氢键供体计数 | 0 |
| 氢键受体计数 | 3 |
| Kovats 保留指数 | 半标准非极性:1913.8 |
| 共价键单元计数 | 1 |
| 同位素原子计数 | 0 |
| 拓扑极性表面积 | 25.4 Ų |
| Collision Cross Section | 161.9 Ų [M+H]+ [CCS类型:TW;方法:Major Mix IMS/Tof校准套件(Waters)] |
| 定义键立体中心计数 | 0 |
| 定义原子立体中心计数 | 0 |
| 未定义键立体中心计数 | 0 |
| 未定义原子手性中心计数 | 1 |
No downstream information yet